The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 kinase.
申请公布号
US8148089(B2)
申请公布日期
2012.04.03
申请号
US20100702201
申请日期
2010.02.08
申请人
ELAN PHARMA INTERNATIONAL LIMITED
发明人
ANDERSON JOHN P.;BANDUCCI KELLY;BASI GURIQBAL S.;CHEREAU DAVID;CHILCOTE TAMIE J.;FRIGON, JR. NORMAND L.;GOLDSTEIN JASON;GRISWOLD IRENE
